You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

 

Online download statistics by month:

Online download statistics by month: July 2021 to July 2025

AbstractFullPdf
Jul 202114661467197
Aug 202118718729
Sep 202110410442
Oct 202114714735
Nov 202190790666
Dec 2021959625
Jan 202217418345
Feb 2022575728
Mar 202210611342
Apr 2022211212500
May 202214214654
Jun 20229610439
Jul 2022838637
Aug 2022889036
Sep 202215715721
Oct 202214214434
Nov 2022919152
Dec 2022555519
Jan 202312612623
Feb 2023838325
Mar 2023606126
Apr 2023424335
May 2023616532
Jun 2023363613
Jul 2023404030
Aug 2023505120
Sep 2023636420
Oct 2023899128
Nov 2023505323
Dec 2023444418
Jan 2024444534
Feb 2024454521
Mar 2024666987
Apr 2024414125
May 2024576230
Jun 2024757539
Jul 2024747725
Aug 2024777766
Sep 2024323827
Oct 2024536141
Nov 2024434515
Dec 2024777821
Jan 2025495022
Feb 2025353723
Mar 2025566717
Apr 202514014139
May 2025768229
Jun 2025404020
Jul 2025110
Total613362332175